SCHEMBL1978296

SCHEMBL1978296

C=CC(C(=O)O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28157180 0.82 LMNA (0.41)
SCHEMBL16994951 0.81
SCHEMBL10695221 0.81
SCHEMBL30826557 0.81 TP53 (0.36)
SCHEMBL98031 0.80 TSHR (0.35)
SCHEMBL3271682 0.78
SCHEMBL18606077 0.78
SCHEMBL6899891 0.77 TP53 (0.42)
SCHEMBL6899896 0.77 TP53 (0.42)
SCHEMBL7602835 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12428421-B2 Pyrimidinones as factor XIA inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2025-09-30 US disclosed
CN-119219557-A Preparation method of beta, gamma-unsaturated nitrile compound 苏州大学 2024-12-31 CN disclosed
CN-119219601-A Preparation method of 4- (2, 2-dimethyl-2-cyanoethyl) -beta-lactam derivative 苏州大学 2024-12-31 CN disclosed
CN-116987080-A Macrocyclic compounds with heterocyclic P2' groups as factor XIA inhibitors 百时美施贵宝公司 2023-11-03 CN disclosed
CN-110845498-B Macrocyclic compounds having heterocyclic P2' groups as factor XIA inhibitors 百时美施贵宝公司 2023-02-17 CN disclosed
EP-3988549-A1 MACROCYCLES WITH HETEROCYCLIC P2' GROUPS AS FACTOR XIA INHIBITORS Bristol-Myers Squibb Company (US) 2022-04-27 EP disclosed
EP-3988549-A1 MACROCYCLES WITH HETEROCYCLIC P2' GROUPS AS FACTOR XIA INHIBITORS Bristol-Myers Squibb Company (US) 2022-04-27 EP disclosed
CN-108250199-B Dihydropyridone P1 as factor XIA inhibitor 百时美施贵宝公司 2021-07-16 CN disclosed
US-11053247-B2 Pyrimidinones as factor XIA inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2021-07-06 US disclosed
US-11053247-B2 Pyrimidinones as factor XIA inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2021-07-06 US disclosed
EP-2739628-A1 NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS Bristol-Myers Squibb Company (US) 2014-06-11 EP disclosed
WO-2014057418-A2 SOLUTION PHASE PROCESSES FOR THE MANUFACTURE OF MACROCYCLIC DEPSIPEPTIDES AND NEW INTERMEDIATES NOVARTIS AG (CH) 2014-04-17 WO disclosed
WO-2014022767-A1 DIHYDROPYRIDONE P1 AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2014-02-06 WO disclosed
US-20140030221-A1 MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES CYPRALIS LIMITED (GB) 2014-01-30 US disclosed
WO-2013022818-A1 NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2013-02-14 WO disclosed
WO-2011069746-A1 REACTIVE COMPOUNDS ON THE BASIS OF TRANSESTERIFICATION EVONIK DEGUSSA GMBH (DE) 2011-06-16 WO disclosed
WO-2007128326-A1 PERFUME DELIVERY SYSTEM FOR CLEANERS EVONIK GOLDSCHMIDT GMBH (DE) 2007-11-15 WO disclosed
US-6124070-A STABILITY UNDER HIGH HUMIDITY AND AT LOW TEMPERATURE-LOW HUMIDITY, FINE PARTICLE SIZE AND A SHARP PARTICLE DIAMETER DISTRIBUTION; COMPRISING A BINDER RESIN, A COLORANT, A METHANOL-SOLUBLE RESIN HAVING ORGANIC ACID GROUPS CANON KABUSHIKI KAISHA (JP) 2000-09-26 US disclosed
EP-0295839-A2 Pyrimidine derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-12-21 EP disclosed
US-3946054-A PERFUMES, TOBACCO, FOOD FLAVORS INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1976-03-23 US disclosed